81919-14-4

Bendazac L-lysine (Bendazaco lisina) is an agent introduced for the management of cataracts, protecting the level of vision in patients, thus delaying the need for surgical intervention.

Bendazac (Standard) is the standard substance of Bendazac, and it is applicable for quantitative analysis, quality control, and related research in biochemical experiments. Bendazac (Bendazolic acid) is an anticataract drug. It may act by preventing protein denaturation.

Bendazac-D7 L-lysine is a deuterated compound of Bendazac L-lysine. Bendazac L-lysine (T3141) has a CAS number of 81919-14-4. Bendazac L-Lysine is an agent introduced for the management of cataracts, protecting the level of vision in patients, thus delaying the need for surgical intervention.

Bendazac-D7 is a deuterated compound of Bendazac. Bendazac (T7807) has a CAS number of 20187-55-7. Bendazac (T7807) is an anticataract drug. It may act by preventing protein denaturation.

Bendazac (Bendazolic acid) is an anticataract drug. It may act by preventing protein denaturation.